SCHEMBL30980693

SCHEMBL30980693

CC(=O)N[C@H]1[C@@H](OCCOCCOCCOCCNC(=O)OC(C)(C)C)O[C@H](COCc2ccccc2)[C@H](OCc2ccccc2)[C@@H]1OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 7/20 0.47
▸ CDC25B P30305 6/20 0.47
▸ PTPN2 P17706 4/20 0.47
▸ CDC25A P30304 3/20 0.47
▸ PTPN6 P29350 1/20 0.47
▸ PTPN11 Q06124 1/20 0.47
▸ TP53 P04637 2/20 0.46
▸ MDM2 Q00987 2/20 0.46
▸ MDM4 O15151 1/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ HSP90AB1 P08238 1/20 0.46
▸ TACR1 P25103 3/20 0.43
▸ NT5E P21589 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ BCHE P06276 1/20 0.39
▸ CNR2 P34972 1/20 0.39
▸ TACR2 P21452 1/20 0.39
▸ IDO1 P14902 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30980750 0.87 PTPN1 (0.47) PTPN1CDC25BPTPN2CDC25APTPN6
SCHEMBL30980588 0.85 NT5E (0.49) PTPN1CDC25BPTPN2CDC25APTPN6
SCHEMBL30980528 0.84 TP53 (0.41) PTPN1CDC25BPTPN2CDC25APTPN6
SCHEMBL15514995 0.84 PTPN1 (0.55) PTPN1CDC25BPTPN2CDC25APTPN6
SCHEMBL30980474 0.84 PTPN1 (0.47) PTPN1CDC25BPTPN2CDC25APTPN6
SCHEMBL24997002 0.83 TACR1 (0.43) PTPN1CDC25BPTPN2CDC25APTPN6
SCHEMBL5840884 0.83 TP53 (0.55) PTPN1CDC25BPTPN2PTPN6PTPN11
SCHEMBL15514084 0.83 TP53 (0.55) PTPN1CDC25BPTPN2PTPN6PTPN11
SCHEMBL5840927 0.83 TP53 (0.55) PTPN1CDC25BPTPN2PTPN6PTPN11
SCHEMBL16967451 0.83 TP53 (0.55) PTPN1CDC25BPTPN2PTPN6PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
EP-4651901-A1 CYCLING LYSOSOMAL TARGETING ANTIBODY CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
WO-2025035040-A1 LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF MUSCLE-SPECIFIC KINASE AUTOANTIBODIES LYCIA THERAPEUTICS, INC. (US) 2025-02-13 — — WO disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
Send feedback